Heavy Proteinuria as a Manifestation of Acute Allograft Rejection Presenting Early after Kidney Transplantation: A Retrospective, Single-Center Case Series

Abstract

The differential diagnosis of heavy proteinuria presenting early after kidney transplantation has generally included de novo or recurrent glomerulonephritis (GN), whereas proteinuria is thought to be an unusual presentation of acute allograft rejection. We retrospectively analyzed the characteristics of 7 patients who presented with early (median 9 days post-transplant) heavy proteinuria with or without renal failure, in association with the development of new donor anti-HLA antibody. End Stage Renal Disease (ESRD) was due to primary GN in three patients. Mean proteinuria at presentation was 7.46 ? 2.44 gm/24 hours. Donor specific anti-HLA antibody was associated with each episode. Diffuse peritubular C4d staining was noted in three cases. Response to therapy with intravenous immunoglobulin G (IVIg) was good, with mean creatinine of 1.48 ? 0.13 mg% at last follow-up of 2-78 months with resolution of proteinuria, and no graft loss. Based on this series, we recommend screening for proteinuria post transplant in all allograft recipients, not only to detect de-novo or recurrent GN in the allograft, but also to detect antibody mediated rejection.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2009
Accession Number
ADA532889

Entities

People

  • Christina M. Yuan
  • Edward M. Falta
  • Eric A. Elster
  • Kevin C. Abbott
  • Rahul M. Jindal
  • Robert T. Neff
  • Scott A. Whitworth
  • Wando Nelson

Organizations

  • Walter Reed Army Medical Center

Tags

DTIC Thesaurus Topics

  • Allografts
  • Antibodies
  • Biological Staining And Labeling
  • Blood
  • Creatinine
  • Diseases And Disorders
  • Governments
  • Health Services
  • Immunoglobulins
  • Kidney Diseases
  • Rejection
  • Standards
  • Transplantation
  • Transplants
  • United States
  • United States Government
  • Urine

Fields of Study

  • Medicine

Readers

  • Molecular and Cellular Biology
  • Neurological Diseases/Conditions/Disorders
  • Trauma Surgery or Emergency Medicine.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech